Literature DB >> 19221965

Exposures and idiopathic lung disease.

Varsha Taskar1, David Coultas.   

Abstract

Of the idiopathic lung diseases, idiopathic pulmonary fibrosis (IPF) and sarcoidosis have been the focus of a growing number of epidemiological investigations on the risk of environmental and occupational exposures. To date, the consistency of epidemiological evidence is suggestive of a causal relationship between several environmental exposures and IPF, with the strongest evidence for cigarette smoking and metal dust. Current knowledge about pathogenesis provides further support for a causal link. However, scant epidemiological evidence for dose-response and temporality weaken the case for making causal inferences. In contrast to IPF, the quantity of epidemiological evidence for environmental exposures and sarcoidosis is smaller. Two studies provide consistent evidence for exposures to agricultural dust and musty odor/mold/mildew, and studies among military personnel and firefighters suggest mixed dust and fume exposures as risk factors for sarcoidosis. Although studies of the pathogenesis of sarcoidosis also provide evidence supporting environmental causation, more epidemiological studies are needed to establish consistency of associations, dose-response, and temporality. Future investigations, of gene-environment interaction offer the potential for strengthening the evidence of causation between several environmental and occupational exposures and idiopathic lung diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19221965     DOI: 10.1055/s-0028-1101277

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  27 in total

1.  Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N'-bis-2-mercaptoethyl isophthalamide.

Authors:  Rishi B Patel; Sainath R Kotha; Lynn A Sauers; Smitha Malireddy; Travis O Gurney; Niladri N Gupta; Terry S Elton; Ulysses J Magalang; Clay B Marsh; Boyd E Haley; Narasimham L Parinandi
Journal:  Toxicol Mech Methods       Date:  2012-06       Impact factor: 2.987

Review 2.  The Role of Aging in Idiopathic Pulmonary Fibrosis.

Authors:  Joseph Leung; Young Cho; Richard F Lockey; Narasaiah Kolliputi
Journal:  Lung       Date:  2015-04-23       Impact factor: 2.584

Review 3.  Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors:  Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

4.  Indoor mildew odour in old housing was associated with adult allergic symptoms, asthma, chronic bronchitis, vision, sleep and self-rated health: USA NHANES, 2005-2006.

Authors:  Ivy Shiue
Journal:  Environ Sci Pollut Res Int       Date:  2015-05-14       Impact factor: 4.223

Review 5.  Genetic susceptibility and pulmonary fibrosis.

Authors:  Susan K Mathai; David A Schwartz; Laura A Warg
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

6.  Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death.

Authors:  Jeffrey J Swigris; Amy L Olson; Tristan J Huie; Evans R Fernandez-Perez; Joshua Solomon; David Sprunger; Kevin K Brown
Journal:  Respir Med       Date:  2012-01-31       Impact factor: 3.415

7.  Themes in fibrosis and gastrointestinal inflammation.

Authors:  Claudio Fiocchi; P Kay Lund
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-17       Impact factor: 4.052

8.  Genetic susceptibility to interstitial pulmonary fibrosis in mice induced by vanadium pentoxide (V2O5).

Authors:  Dianne M Walters; Kevin M White; Ushma Patel; Martin J Davis; Roberta M Veluci-Marlow; Solomon Raju Bhupanapadu Sunkesula; James C Bonner; Jessica R Martin; Wes Gladwell; Steven R Kleeberger
Journal:  FASEB J       Date:  2013-11-27       Impact factor: 5.191

Review 9.  Matrix Remodeling in Pulmonary Fibrosis and Emphysema.

Authors:  Tejaswini Kulkarni; Philip O'Reilly; Veena B Antony; Amit Gaggar; Victor J Thannickal
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

10.  Safety of prolonged, repeated administration of a pulmonary formulation of tissue plasminogen activator in mice.

Authors:  Nicholas P Lackowski; Josh E Pitzer; Meghan Tobias; Zachary Van Rheen; Rajiv Nayar; Mitra Mosharaff; Kathleen A Stringer
Journal:  Pulm Pharmacol Ther       Date:  2009-10-29       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.